The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Mayo Clinic
Tizona Therapeutics, Inc
University of California, San Diego
BioNTech SE
University of California, San Diego
VM Oncology, LLC
Memorial Sloan Kettering Cancer Center
University of Chicago
BioAtla, Inc.
Incyte Corporation
NuCana plc
University of Wisconsin, Madison
Medicenna Therapeutics, Inc.
Vaccinex Inc.
CJ Bioscience, Inc.
Carisma Therapeutics Inc
Nykode Therapeutics ASA
NextCure, Inc.
UNICANCER
Salubris Biotherapeutics Inc
University of California, San Francisco
SQZ Biotechnologies
Rutgers, The State University of New Jersey
Providence Health & Services
Seagen Inc.
Incyte Corporation
MultiVir, Inc.